Cocrystal Pharma (COCP) Accounts Payables (2010 - 2026)
Cocrystal Pharma (COCP) posted Accounts Payables of $1.9 million for Q1 2026, up 111.91% sequentially from $890000.0 in Q4 2025, and up 16.28% YoY from $1.6 million in Q1 2025.
Cocrystal Pharma (COCP) Accounts Payables (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Accounts Payables for 15 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Accounts Payables rose 16.28% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 16.28% YoY) and the FY2025 annual result came in at $890000.0, down 42.28% from the prior year.
- Accounts Payables rose to $1.9 million in Q1 2026 per COCP's latest filing, from $890000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $3.0 million in Q4 2023 and troughed at $568000.0 in Q3 2023.
- A 5-year average of $1.5 million and a median of $1.4 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables surged 242.31% in 2023, then slumped 57.98% in 2024.
- Over 5 years, Accounts Payables stood at $976000.0 in 2022, then soared by 209.63% to $3.0 million in 2023, then sank by 48.97% to $1.5 million in 2024, then tumbled by 42.28% to $890000.0 in 2025, then surged by 111.91% to $1.9 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.9 million, $890000.0, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.26 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 890,000.00 |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 3.02 Mn |
| Sep 30, 2023 | 568,000.00 |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 2.94 Mn |
| Dec 31, 2022 | 976,000.00 |
| Sep 30, 2022 | 897,000.00 |
| Jun 30, 2022 | 971,000.00 |
| Mar 31, 2022 | 858,000.00 |
| Dec 31, 2021 | 1.30 Mn |
| Sep 30, 2021 | 961,000.00 |